There is a shortage of nurses in the U.S. that’s particularly worse in nursing homes than in hospitals. Long-term facility employment is 7.4% lower today than the staffing levels of
Lilly’s newest obesity and diabetes medicines, widely known as GLP-1 drugs, are drawing rave reviews from doctors, researchers and patients for their ability to safely and effectively control blood sugar and take off weight.